Global Gene Therapies for Cancer Treatment Competitive Landscape Professional Research Report 2025
Research Summary
Gene therapies for cancer treatment involve the introduction or modification of genetic material within a patient＇s cells to target and combat cancer. This innovative approach aims to address underlying genetic abnormalities responsible for the development and progression of cancer. Various strategies are employed, including introducing therapeutic genes, modifying existing genes, or utilizing gene editing technologies to enhance the body＇s ability to recognize and eliminate cancer cells. One prominent example involves using viral vectors to deliver therapeutic genes that instruct the immune system to recognize and attack cancer cells specifically. CAR-T cell therapy is a notable gene therapy for certain blood cancers, where a patient＇s T cells are engineered to express chimeric antigen receptors (CARs), allowing them to target and destroy cancer cells with precision. While gene therapies for cancer are still evolving, they represent a promising avenue for personalized and targeted treatment approaches, potentially revolutionizing cancer care by addressing the genetic basis of the disease. Ongoing research and clinical trials continue to explore and refine these therapeutic strategies.
According to DIResearch's in-depth investigation and research, the global Gene Therapies for Cancer Treatment market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Gene Therapies for Cancer Treatment include Takara Bio, Tocagen, VBL Therapeutics, Cold Genesys, Genprex, Momotaro-Gene, MultiVir, SynerGene Therapeutics, Ziopharm Oncology, Anchiano Therapeutics, Celsion, Celgene, Bluebird Bio etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Gene Therapies for Cancer Treatment. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Gene Therapies for Cancer Treatment market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Gene Therapies for Cancer Treatment market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gene Therapies for Cancer Treatment industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Gene Therapies for Cancer Treatment Include:
Takara Bio
Tocagen
VBL Therapeutics
Cold Genesys
Genprex
Momotaro-Gene
MultiVir
SynerGene Therapeutics
Ziopharm Oncology
Anchiano Therapeutics
Celsion
Celgene
Bluebird Bio
Gene Therapies for Cancer Treatment Product Segment Include:
Somatic Cell Gene Therapy (SCGT)
Germline Gene Therapy (GGT)
Gene Therapies for Cancer Treatment Product Application Include:
Cancer Research Centers
Diagnostic Laboratories
Cancer Hospitals
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Gene Therapies for Cancer Treatment Industry PESTEL Analysis
Chapter 3: Global Gene Therapies for Cancer Treatment Industry Porter’s Five Forces Analysis
Chapter 4: Global Gene Therapies for Cancer Treatment Major Regional Market Size and Forecast Analysis
Chapter 5: Global Gene Therapies for Cancer Treatment Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Gene Therapies for Cancer Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Gene Therapies for Cancer Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Gene Therapies for Cancer Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Gene Therapies for Cancer Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Gene Therapies for Cancer Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Gene Therapies for Cancer Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Gene Therapies for Cancer Treatment Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Gene Therapies for Cancer Treatment Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Gene Therapies for Cancer Treatment Product by Type
- 1.2.1 Somatic Cell Gene Therapy (SCGT)
- 1.2.2 Germline Gene Therapy (GGT)
- 1.3 Gene Therapies for Cancer Treatment Product by Application
- 1.3.1 Cancer Research Centers
- 1.3.2 Diagnostic Laboratories
- 1.3.3 Cancer Hospitals
- 1.3.4 Others
- 1.4 Global Gene Therapies for Cancer Treatment Market Size Analysis (2020-2032)
- 1.5 Gene Therapies for Cancer Treatment Market Development Status and Trends
- 1.5.1 Gene Therapies for Cancer Treatment Industry Development Status Analysis
- 1.5.2 Gene Therapies for Cancer Treatment Industry Development Trends Analysis
- 2 Gene Therapies for Cancer Treatment Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Gene Therapies for Cancer Treatment Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Gene Therapies for Cancer Treatment Market Analysis by Regions
- 4.1 Gene Therapies for Cancer Treatment Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Gene Therapies for Cancer Treatment Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Gene Therapies for Cancer Treatment Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Gene Therapies for Cancer Treatment Revenue Forecast by Region (2026-2032)
- 5 Global Gene Therapies for Cancer Treatment Market Size by Type and Application
- 5.1 Global Gene Therapies for Cancer Treatment Market Size by Type (2020-2032)
- 5.2 Global Gene Therapies for Cancer Treatment Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Gene Therapies for Cancer Treatment Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Gene Therapies for Cancer Treatment Market Size by Type
- 6.4 North America Gene Therapies for Cancer Treatment Market Size by Application
- 6.5 North America Gene Therapies for Cancer Treatment Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Gene Therapies for Cancer Treatment Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Gene Therapies for Cancer Treatment Market Size by Type
- 7.4 Europe Gene Therapies for Cancer Treatment Market Size by Application
- 7.5 Europe Gene Therapies for Cancer Treatment Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Gene Therapies for Cancer Treatment Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Gene Therapies for Cancer Treatment Market Size by Type
- 8.4 China Gene Therapies for Cancer Treatment Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Gene Therapies for Cancer Treatment Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Gene Therapies for Cancer Treatment Market Size by Type
- 9.4 APAC (excl. China) Gene Therapies for Cancer Treatment Market Size by Application
- 9.5 APAC (excl. China) Gene Therapies for Cancer Treatment Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Gene Therapies for Cancer Treatment Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Gene Therapies for Cancer Treatment Market Size by Type
- 10.4 Latin America Gene Therapies for Cancer Treatment Market Size by Application
- 10.5 Latin America Gene Therapies for Cancer Treatment Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Gene Therapies for Cancer Treatment Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Type
- 11.4 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Application
- 11.5 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Gene Therapies for Cancer Treatment Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Gene Therapies for Cancer Treatment Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Gene Therapies for Cancer Treatment Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Takara Bio
- 13.1.1 Takara Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Takara Bio Gene Therapies for Cancer Treatment Product Portfolio
- 13.1.3 Takara Bio Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Tocagen
- 13.2.1 Tocagen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Tocagen Gene Therapies for Cancer Treatment Product Portfolio
- 13.2.3 Tocagen Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 VBL Therapeutics
- 13.3.1 VBL Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 VBL Therapeutics Gene Therapies for Cancer Treatment Product Portfolio
- 13.3.3 VBL Therapeutics Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Cold Genesys
- 13.4.1 Cold Genesys Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Cold Genesys Gene Therapies for Cancer Treatment Product Portfolio
- 13.4.3 Cold Genesys Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Genprex
- 13.5.1 Genprex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Genprex Gene Therapies for Cancer Treatment Product Portfolio
- 13.5.3 Genprex Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Momotaro-Gene
- 13.6.1 Momotaro-Gene Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Momotaro-Gene Gene Therapies for Cancer Treatment Product Portfolio
- 13.6.3 Momotaro-Gene Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 MultiVir
- 13.7.1 MultiVir Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 MultiVir Gene Therapies for Cancer Treatment Product Portfolio
- 13.7.3 MultiVir Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 SynerGene Therapeutics
- 13.8.1 SynerGene Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 SynerGene Therapeutics Gene Therapies for Cancer Treatment Product Portfolio
- 13.8.3 SynerGene Therapeutics Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Ziopharm Oncology
- 13.9.1 Ziopharm Oncology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Ziopharm Oncology Gene Therapies for Cancer Treatment Product Portfolio
- 13.9.3 Ziopharm Oncology Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Anchiano Therapeutics
- 13.10.1 Anchiano Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Anchiano Therapeutics Gene Therapies for Cancer Treatment Product Portfolio
- 13.10.3 Anchiano Therapeutics Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Celsion
- 13.11.1 Celsion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Celsion Gene Therapies for Cancer Treatment Product Portfolio
- 13.11.3 Celsion Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 Celgene
- 13.12.1 Celgene Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Celgene Gene Therapies for Cancer Treatment Product Portfolio
- 13.12.3 Celgene Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 Bluebird Bio
- 13.13.1 Bluebird Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Bluebird Bio Gene Therapies for Cancer Treatment Product Portfolio
- 13.13.3 Bluebird Bio Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Gene Therapies for Cancer Treatment Industry Chain Analysis
- 14.2 Gene Therapies for Cancer Treatment Industry Raw Material and Suppliers Analysis
- 14.2.1 Gene Therapies for Cancer Treatment Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Gene Therapies for Cancer Treatment Typical Downstream Customers
- 14.4 Gene Therapies for Cancer Treatment Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook